New PBM contracting entities, often categorized as group purchasing organizations, add another obstacle to industry transparency
Cigna restricts coverage for Amylyx Pharmaceutical’s ALS drug Relyvrio due to the lack of clinical efficacy data and unclear clinical benefit
J&J has been cleared to continue a lawsuit filed last year against drug benefit program SaveOnSP
AMI’s new report, Primary Care Providers: Evolving in 2023-2024 provides a background of the primary care market and profiles the companies that will be leading the market in 2023 and beyond
Cigna recently launched Cigna Pathwell Specialty to offer access to a specialty pharmacy network for infusion and infection drugs, which is designed to be national and cost-effective
In the area of specialty pharmacy services, the Kaiser-Evernorth agreement seeks to deliver overall value and savings to Kaiser Permanente and its commercial plan members
RightwayRx Offers Employers An Alternative to the Big 3 PBMs
Amazon Pharmacy is partnering with Blue Plans in five states and Prime Therapeutics (Prime) to address the affordability of prescription medications